IFM Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
855 Boylston St Fl 11, Boston, Massachus...Phone Number
(857) 304-0583Website
www.ifmthera.comRevenue
$23 MillionIndustry
About IFM Therapeutics
IFM Therapeutics is dedicated to enhancing the lives of patients suffering from inflammation-driven diseases and cancer by developing innovative medicines that target the innate immune system. The company focuses on creating first-in-class small molecules that regulate immune responses across various disease indications. With a strong track record of advancing novel programs from discovery to clinical studies, IFM Therapeutics aims to address the urgent needs of patients. Their portfolio includes several promising drug candidates currently in various stages of development.Explore more
IFM Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to IFM Therapeutics
Compare insights from companies similar to IFM Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
IFM Therapeutics Tech Stack
A closer look at the technologies used by IFM Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IFM Therapeutics
Sign Up For FreeTo access detailed company insights
IFM Therapeutics is dedicated to enhancing the lives of patients suffering from inflammation-driven diseases and cancer by developing innovative medicines that target the innate immune system. The company focuses on creating first-in-class small molecules that regulate immune responses across various disease indications. With a strong track record... Read More
